VEXT Science, Inc. belongs to the Health Care sector. Filings by its managers are published through SEDI. Over the twelve months to 22 October 2026, 5 filings were filed, from 1 insider.
Only sales appear on the open market, 5 sales in all totalling €47k, filed by 1 insider. Smith, Trevor Richard filed the largest sale, €22k, on 30 December 2025.
Typically, a trade is published a median of 1 day after it takes place. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
With 5 filings in twelve months, the company is quieter than the median of 12 filings across the 2,473 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 35 purchases and 7 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at UCB. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Analysts rate VEXT Science, Inc. Strong Buy (bullish), based on 1 analysts. Average price target: CA$0.95.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 57 declarations
VEXT Science, Inc. is a publicly traded company on the Toronto Stock Exchange that focuses on developing cannabis-related products. It offers innovative solutions for the legal cannabis market.
Purchases our model currently ranks for the recommendations list.
All recommendations